Bausch + Lomb Corporation

16.28-0.0800-0.49%Vol 584.42K1Y Perf 0.74%
Oct 3rd, 2023 16:00 DELAYED
BID15.93 ASK16.71
Open16.27 Previous Close16.36
Pre-Market- After-Market16.28
 - -  - -%
Target Price
19.83 
Analyst Rating
Moderate Buy 2.22
Potential %
21.81 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     40.75
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     41.22
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
38.10 
Earnings Rating
Market Cap5.71B 
Earnings Date
1st Nov 2023
Alpha0.00 Standard Deviation0.07
Beta0.22 

Today's Price Range

16.1216.49

52W Range

12.7921.95

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-4.05%
1 Month
-8.86%
3 Months
-19.73%
6 Months
-3.65%
1 Year
0.74%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BLCO16.28-0.0800-0.49
AAPL172.40-1.3500-0.78
GOOG133.30-1.8700-1.38
MSFT313.39-8.4100-2.61
XOM115.830.20000.17
WFC38.67-0.9400-2.37
JNJ155.340.19000.12
FB196.640.99000.51
GE107.76-1.0300-0.95
JPM142.71-1.0600-0.74
Financial StrengthValueIndustryS&P 500US Markets
0.80
1.60
0.26
0.36
2.60
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
59.90
7.60
17.90
-
0.54
RevenueValueIndustryS&P 500US Markets
2.86B
8.18
-0.28
-
Earnings HistoryEstimateReportedSurprise %
Q02 20230.160.1812.50
Q01 20230.140.10-28.57
Q04 20220.220.234.55
Q03 20220.230.3134.78
Q02 20220.200.2945.00
Q01 2022-0.06-
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date1st Nov 2023
Estimated EPS Next Report0.17
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume584.42K
Shares Outstanding350.70K
Shares Float40.16M
Trades Count5.87K
Dollar Volume9.51M
Avg. Volume477.33K
Avg. Weekly Volume507.05K
Avg. Monthly Volume458.57K
Avg. Quarterly Volume466.36K

Bausch + Lomb Corporation (NYSE: BLCO) stock closed at 16.36 per share at the end of the most recent trading day (a -3.48% change compared to the prior day closing price) with a volume of 860.31K shares and market capitalization of 5.71B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 19600 people. Bausch + Lomb Corporation CEO is .

The one-year performance of Bausch + Lomb Corporation stock is 0.74%, while year-to-date (YTD) performance is 5.48%. BLCO stock has a five-year performance of %. Its 52-week range is between 12.79 and 21.95, which gives BLCO stock a 52-week price range ratio of 38.10%

Bausch + Lomb Corporation currently has a PE ratio of 110.00, a price-to-book (PB) ratio of 0.83, a price-to-sale (PS) ratio of 1.98, a price to cashflow ratio of 16.10, a PEG ratio of -, a ROA of 0.58%, a ROC of 0.54% and a ROE of 0.79%. The company’s profit margin is 0.54%, its EBITDA margin is 17.90%, and its revenue ttm is $2.86 Billion , which makes it $8.18 revenue per share.

Of the last four earnings reports from Bausch + Lomb Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.17 for the next earnings report. Bausch + Lomb Corporation’s next earnings report date is 01st Nov 2023.

The consensus rating of Wall Street analysts for Bausch + Lomb Corporation is Moderate Buy (2.22), with a target price of $19.83, which is +21.81% compared to the current price. The earnings rating for Bausch + Lomb Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bausch + Lomb Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bausch + Lomb Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 67.03, ATR14 : 0.46, CCI20 : -167.69, Chaikin Money Flow : -0.12, MACD : -0.45, Money Flow Index : 43.47, ROC : -7.67, RSI : 29.53, STOCH (14,3) : 12.17, STOCH RSI : 0.00, UO : 41.25, Williams %R : -87.83), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bausch + Lomb Corporation in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (33.33 %)
3 (33.33 %)
3 (33.33 %)
Moderate Buy
1 (11.11 %)
1 (11.11 %)
1 (11.11 %)
Hold
5 (55.56 %)
5 (55.56 %)
5 (55.56 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.22
Moderate Buy
2.22
Moderate Buy
2.22

Bausch + Lomb Corporation

Bausch & Lomb Corp is a global eye health company dedicated towards protecting and enhancing the gift of sight for millions of people around the world. It holds portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.

CEO:

Telephone: +1 905 695-7700

Address: 520 Applewood Crescent, Vaughan L4K 4B4, ON, CA

Number of employees: 19 600

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

51%49%

Bearish Bullish

53%48%

 

TipRanks News for BLCO

Fri, 29 Sep 2023 14:05 GMT Novartis completes divestment of front of eye ophthalmology assets

- TipRanks. All rights reserved.

Fri, 29 Sep 2023 14:02 GMT Bausch + Lomb completes acquisition of Xiidra from Novartis

- TipRanks. All rights reserved.

Mon, 03 Jul 2023 10:05 GMT Bausch + Lomb Corporation (BLCO) Receives a Hold from Barclays

- TipRanks. All rights reserved.

News

Stocktwits